查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1522227

2024 年心臟病學和神經病學 IVD 全球市場報告

In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

心臟和神經科 IVD 市場規模預計在未來幾年將強勁成長，預計到 2028 年將成長至 221.8 億美元，複合年成長率為 8.8%。預測期內的預期成長是由循環系統和神經科向個人化醫療的轉變、這些領域對快速和現場測試解決方案的需求不斷增加、遠端醫療和遠距會診服務的擴展以及研究推動的，這是由於多種因素造成的，包括活動增加。在此期間預計的重要趨勢包括液態切片技術的出現、奈米技術應用的進步、植入式心臟監視器和腦機介面等遠端監控設備的採用、多重生物標記物面板的使用、MRI、這些包括醫療領域的進步CT 和 PET 掃描等影像方式，以及心臟病學和神經病學 IVD 的開發。

在可預見的未來，個人化醫療的擴張可能會推動心臟和神經 IVD 市場的發展。個人化醫療是根據個別患者特徵量身定做醫療干預和治療，其促進因素包括基因組分析的進步、對疾病機制了解的加深、患者對客製化治療的需求以及監管支持的不斷發展。在心臟病學和神經病學領域，IVD 測試透過提供對個別基因組成和疾病狀態的重要洞察，在促進個人化醫療方面發揮關鍵作用。這些見解指導客製化治療策略的製定，從而提高療效並最大限度地降低風險。例如，根據個人化醫療聯盟的資料，到2022年，約34%的新核准治療方法將是個人化醫療，比往年大幅增加。因此，個人化藥物的日益普及正在推動心臟病學和神經學 IVD 市場的成長。

心臟和神經 IVD 市場的主要企業正在創新人工智慧主導的整合表觀遺傳系統，以實現早期疾病檢測和風險評估。透過利用機器學習和先進的生物標記分析技術，這些人工智慧主導的整合表觀遺傳系統將提高心血管疾病診斷和監測的準確性和敏感性，從而影響疾病進展的關鍵因素。例如，2023 年 2 月，美國生物技術公司 Cardio Diagnostics Holdings Inc. 推出了 PrecisionCHD，這是一種由人工智慧驅動的血液測試，旨在及時識別心臟疾病(CHD)。該測試由該公司整合的表觀遺傳和遺傳引擎提供支持，可評估冠心病的易感性，並力求及早發現最常見的心血管疾病。透過將表觀遺傳和遺傳指標與機器學習演算法結合，這項新測試對男性和女性的敏感性均超過 75%。該測試建立了患者的生物標記特徵與可改變的危險因素之間的關聯，例如吸煙、糖尿病、高血壓和膽固醇水平升高，這些因素對冠心病有顯著影響。 PrecisionCHD 提供了運動壓力測試和血管造影術等傳統方法的非侵入性替代方法，因為它需要在診所或家中收集血液樣本。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 市場促進和限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年市場規模表現與成長
  • 市場規模預測與成長，2023-2028，2033F

第6章 市場細分

  • 全球心臟病學和神經病學 IVD 市場：按產品類型分類的績效和預測，2018-2023、2023-2028F、2033F
  • 裝置
  • 試劑及耗材
  • 軟體和服務
  • 全球心臟病學和神經病學 IVD 市場：按技術分類的表現和預測，2018-2023、2023-2028F、2033F
  • 免疫測量
  • 分子診斷
  • 血液學
  • 其他
  • 全球心臟病學和神經病學 IVD 市場：最終用戶的表現和預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 臨床實驗室
  • 其他

第 7 章 區域/國家分析

  • 全球心臟病學和神經病學 IVD 市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球心臟病學和神經病學 IVD 市場：按國家/地區分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 心臟病和神經病學 IVD 市場：競爭格局
  • 心臟病學/神經學 IVD 市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第31章 其他大型創新企業

  • Becton Dickinson And Company
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • Illumina Inc.
  • Beckman Coulter Inc.
  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Instrumentation Laboratory
  • bioMerieux SA
  • Natera, Inc.
  • Randox Laboratories Ltd.
  • Fulgent Genetics Inc.
  • DiaSorin SpA

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18380

In vitro diagnostic (IVD) in cardiology and neurology involves conducting medical tests on samples such as blood, urine, or tissue outside the body to diagnose a range of cardiovascular and neurological ailments. These tests are pivotal for detecting conditions such as heart disease, stroke, Alzheimer's disease, and more, aiding in early diagnosis, ongoing monitoring, and treatment planning. They offer timely diagnostic insights crucial for guiding patient care and enhancing outcomes in both cardiology and neurology.

The main products of in vitro diagnostic (IVD) in cardiology and neurology encompass instruments, reagents and consumables, and software and services. Instruments denote the tools or apparatuses utilized for conducting diagnostic examinations and scrutinizing patient specimens within laboratory environments. These encompass various technologies such as immunoassays, molecular diagnostics, and hematology, catering to the needs of hospitals, clinical laboratories, and similar entities.

The in vitro diagnostic (IVD) in cardiology and neurology market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostic (IVD) in cardiology and neurology market statistics, including the in vitro diagnostic (IVD) in cardiology and neurology industry global market size, regional shares, competitors with in vitro diagnostic (IVD) in cardiology and neurology market share, detailed in vitro diagnostic (IVD) in cardiology and neurology market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostic (IVD) in cardiology and neurology industry. This in vitro diagnostic (IVD) in cardiology and neurology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostic (IVD) in cardiology and neurology market size has grown strongly in recent years. It will grow from $14.58 billion in 2023 to $15.84 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the increasing burden of cardiovascular diseases (CVDs) and neurological disorders, such as stroke and Alzheimer's disease, rise in the prevalence of age-related cardiovascular and neurological disorders, rise in the aging population, growing emphasis on preventive healthcare and early disease detection, rise in supportive regulatory frameworks governing the approval and reimbursement of diagnostic tests and rise in investments in healthcare infrastructure.

The in vitro diagnostic (IVD) in cardiology and neurology market size is expected to see strong growth in the next few years. It will grow to $22.18 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to several factors, including the transition towards personalized medicine in cardiology and neurology, heightened demand for swift and on-site testing solutions within these fields, the expansion of telemedicine and remote consultation services, and an increase in research endeavors. Significant trends expected during this period encompass the emergence of liquid biopsy technologies, progress in nanotechnology applications, the adoption of remote monitoring devices such as implantable cardiac monitors and brain-computer interfaces, utilization of multiplex biomarker panels, advancements in medical imaging modalities such as MRI, CT, and PET scans, and the development of companion diagnostics tailored for cardiovascular and neurological medications.

The expansion of personalized medicine is poised to drive the advancement of the in vitro diagnostic (IVD) market in cardiology and neurology in the foreseeable future. Personalized medicine, which customizes healthcare interventions and treatments to suit the unique characteristics of individual patients, is gaining momentum due to progress in genomics, enhanced understanding of disease mechanisms, patient demand for tailored therapies, and regulatory backing, among other factors. In cardiology and neurology, IVD tests play a pivotal role in facilitating personalized medicine by furnishing essential insights into an individual's genetic composition and disease status. These insights guide the development of customized treatment strategies, thereby enhancing efficacy and minimizing risks. For instance, data from the Personalized Medicine Coalition indicates that in 2022, approximately 34% of all newly approved therapies were personalized medicines, marking a significant rise from previous years. Hence, the escalating adoption of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) market in cardiology and neurology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are innovating AI-driven integrated epigenetic systems to enable early detection of diseases and assess risks. These AI-enabled integrated epigenetic systems utilize machine learning and advanced biomarker analysis methods to improve the precision and sensitivity of diagnosing and monitoring cardiovascular conditions, thereby targeting key factors influencing disease advancement. For example, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology firm, introduced PrecisionCHD, an AI-powered blood test engineered for the timely identification of coronary heart disease (CHD). Employing the company's integrated epigenetic-genetic engine, this test evaluates CHD susceptibility and strives to preemptively detect the most prevalent cardiovascular ailment. Combining epigenetic and genetic indicators with machine learning algorithms, the new test delivers over 75% sensitivity for both genders. It establishes a connection between a patient's biomarker profile and modifiable risk elements, such as smoking, diabetes, hypertension, and elevated cholesterol levels, which significantly contribute to CHD. PrecisionCHD presents a non-invasive option to conventional methods such as exercise stress tests or angiograms, as it requires blood samples collected either at the clinic or home.

In September 2021, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a Chinese company known for its medical devices and solutions, purchased HyTest Ltd. for $661 million. Through this acquisition, Mindray aims to bolster its position in the in-vitro diagnostics (IVD) sector by leveraging HyTest's proficiency in antibodies and antigens, particularly in areas such as cardiac markers, inflammation, tumor markers, and infectious diseases. HyTest Ltd., headquartered in Finland, specializes in diagnostic test materials, including in vitro diagnostic biomarkers for cardiology.

Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMerieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience

North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostic (IVD) in cardiology and neurology market consists of revenues earned by entities by providing services such as point-of-care testing, laboratory testing, molecular diagnostics, and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostic (IVD) in cardiology and neurology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostic (IVD) in cardiology and neurology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostic (IVD) in cardiology and neurology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
  • 2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
  • 3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Characteristics

3. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Trends And Strategies

4. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Size and Growth

  • 5.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Segmentation

  • 6.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software And Services
  • 6.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunoassays
  • Molecular Diagnostics
  • Hematology
  • Other Technologies
  • 6.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Other End-Users

7. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 8.1. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 9.1. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 9.2. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 10.1. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 11.1. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 11.2. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 12.1. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 13.1. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 14.1. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 14.2. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 15.1. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 15.2. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 16.1. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 17.1. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 18.1. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 19.1. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 20.1. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 21.1. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 21.2. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 22.1. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 23.1. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 23.2. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 24.1. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 24.2. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 25.1. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 25.2. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 26.1. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 26.2. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 27.1. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 28.1. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 28.2. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

  • 29.1. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
  • 29.2. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape And Company Profiles

  • 30.1. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape
  • 30.2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson And Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Hologic Inc.
  • 31.4. Illumina Inc.
  • 31.5. Beckman Coulter Inc.
  • 31.6. Quidel Corporation
  • 31.7. Sysmex Corporation
  • 31.8. Bio-Rad Laboratories Inc.
  • 31.9. QIAGEN N.V.
  • 31.10. Instrumentation Laboratory
  • 31.11. bioMerieux SA
  • 31.12. Natera, Inc.
  • 31.13. Randox Laboratories Ltd.
  • 31.14. Fulgent Genetics Inc.
  • 31.15. DiaSorin S.p.A.

32. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Benchmarking

33. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market

35. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Future Outlook and Potential Analysis

  • 35.1 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer